Effects of gabapentin and carbamazepine on the EEG and cognition in healthy volunteers

Martin Salinsky, Lawrence M. Binder, Barry Oken, Daniel Storzbach, Carey R. Aron, Carl B. Dodrill

Research output: Contribution to journalArticle

103 Citations (Scopus)

Abstract

Purpose: Antiepileptic drug (AED) therapy can be associated with neurotoxic side effects including cognitive dysfunction. Objective methods for detection of neurotoxicity in individual patients would be useful. We studied the effects of gabapentin (GBP) and carbamazepine (CBZ) on neurophysiologic and cognitive/behavioral measures in healthy volunteers. Methods: In a 12-week, randomized, double-blind, parallel-group study of CBZ and GBP in healthy volunteers, 23 subjects completed the protocol. All achieved the target dose of 1,200 mg CBZ or 3,600 mg GBP. A structured EEG for quantitative analysis and a cognitive test battery were administered before AED therapy and again after 12 weeks of therapy. Test-retest differences were compared with those of 72 untreated control subjects. Results: Both CBZ and GBP significantly decreased the peak frequency of the posterior (alpha) rhythm, with CBZ exerting a greater effect. Ten CBZ and six GBP subjects exceeded the 95% confidence interval (CI) for an individual. Cognitive tests revealed AED vs. control group effects for two of seven measures (Digit Symbol, Stroop) and all subjective measures. However, few subjects exceeded the 95% CI for any objective test. Differences between CBZ and GBP were not significant. Greater EEG slowing was associated with greater subjective neurotoxicity and poorer test-retest performance on a cognitive test summary measure. Conclusions: Prolonged CBZ and GBP therapy induced EEG slowing that correlated with cognitive complaints and often exceeded the confidence interval for individual subjects. Quantitative EEG measures may be useful in the objective determination of AED-related neurotoxicity.

Original languageEnglish (US)
Pages (from-to)482-490
Number of pages9
JournalEpilepsia
Volume43
Issue number5
DOIs
StatePublished - 2002

Fingerprint

Carbamazepine
Cognition
Electroencephalography
Healthy Volunteers
Anticonvulsants
Confidence Intervals
Alpha Rhythm
Drug Therapy
gabapentin
Control Groups
Therapeutics

Keywords

  • Antiepileptic drugs
  • Carbamazepine
  • Cognition
  • Electroencephalography
  • Epilepsy
  • Gabapentin

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Effects of gabapentin and carbamazepine on the EEG and cognition in healthy volunteers. / Salinsky, Martin; Binder, Lawrence M.; Oken, Barry; Storzbach, Daniel; Aron, Carey R.; Dodrill, Carl B.

In: Epilepsia, Vol. 43, No. 5, 2002, p. 482-490.

Research output: Contribution to journalArticle

Salinsky, Martin ; Binder, Lawrence M. ; Oken, Barry ; Storzbach, Daniel ; Aron, Carey R. ; Dodrill, Carl B. / Effects of gabapentin and carbamazepine on the EEG and cognition in healthy volunteers. In: Epilepsia. 2002 ; Vol. 43, No. 5. pp. 482-490.
@article{62f3930367004928beb4ca2729e5f9cc,
title = "Effects of gabapentin and carbamazepine on the EEG and cognition in healthy volunteers",
abstract = "Purpose: Antiepileptic drug (AED) therapy can be associated with neurotoxic side effects including cognitive dysfunction. Objective methods for detection of neurotoxicity in individual patients would be useful. We studied the effects of gabapentin (GBP) and carbamazepine (CBZ) on neurophysiologic and cognitive/behavioral measures in healthy volunteers. Methods: In a 12-week, randomized, double-blind, parallel-group study of CBZ and GBP in healthy volunteers, 23 subjects completed the protocol. All achieved the target dose of 1,200 mg CBZ or 3,600 mg GBP. A structured EEG for quantitative analysis and a cognitive test battery were administered before AED therapy and again after 12 weeks of therapy. Test-retest differences were compared with those of 72 untreated control subjects. Results: Both CBZ and GBP significantly decreased the peak frequency of the posterior (alpha) rhythm, with CBZ exerting a greater effect. Ten CBZ and six GBP subjects exceeded the 95{\%} confidence interval (CI) for an individual. Cognitive tests revealed AED vs. control group effects for two of seven measures (Digit Symbol, Stroop) and all subjective measures. However, few subjects exceeded the 95{\%} CI for any objective test. Differences between CBZ and GBP were not significant. Greater EEG slowing was associated with greater subjective neurotoxicity and poorer test-retest performance on a cognitive test summary measure. Conclusions: Prolonged CBZ and GBP therapy induced EEG slowing that correlated with cognitive complaints and often exceeded the confidence interval for individual subjects. Quantitative EEG measures may be useful in the objective determination of AED-related neurotoxicity.",
keywords = "Antiepileptic drugs, Carbamazepine, Cognition, Electroencephalography, Epilepsy, Gabapentin",
author = "Martin Salinsky and Binder, {Lawrence M.} and Barry Oken and Daniel Storzbach and Aron, {Carey R.} and Dodrill, {Carl B.}",
year = "2002",
doi = "10.1046/j.1528-1157.2002.22501.x",
language = "English (US)",
volume = "43",
pages = "482--490",
journal = "Epilepsia",
issn = "0013-9580",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Effects of gabapentin and carbamazepine on the EEG and cognition in healthy volunteers

AU - Salinsky, Martin

AU - Binder, Lawrence M.

AU - Oken, Barry

AU - Storzbach, Daniel

AU - Aron, Carey R.

AU - Dodrill, Carl B.

PY - 2002

Y1 - 2002

N2 - Purpose: Antiepileptic drug (AED) therapy can be associated with neurotoxic side effects including cognitive dysfunction. Objective methods for detection of neurotoxicity in individual patients would be useful. We studied the effects of gabapentin (GBP) and carbamazepine (CBZ) on neurophysiologic and cognitive/behavioral measures in healthy volunteers. Methods: In a 12-week, randomized, double-blind, parallel-group study of CBZ and GBP in healthy volunteers, 23 subjects completed the protocol. All achieved the target dose of 1,200 mg CBZ or 3,600 mg GBP. A structured EEG for quantitative analysis and a cognitive test battery were administered before AED therapy and again after 12 weeks of therapy. Test-retest differences were compared with those of 72 untreated control subjects. Results: Both CBZ and GBP significantly decreased the peak frequency of the posterior (alpha) rhythm, with CBZ exerting a greater effect. Ten CBZ and six GBP subjects exceeded the 95% confidence interval (CI) for an individual. Cognitive tests revealed AED vs. control group effects for two of seven measures (Digit Symbol, Stroop) and all subjective measures. However, few subjects exceeded the 95% CI for any objective test. Differences between CBZ and GBP were not significant. Greater EEG slowing was associated with greater subjective neurotoxicity and poorer test-retest performance on a cognitive test summary measure. Conclusions: Prolonged CBZ and GBP therapy induced EEG slowing that correlated with cognitive complaints and often exceeded the confidence interval for individual subjects. Quantitative EEG measures may be useful in the objective determination of AED-related neurotoxicity.

AB - Purpose: Antiepileptic drug (AED) therapy can be associated with neurotoxic side effects including cognitive dysfunction. Objective methods for detection of neurotoxicity in individual patients would be useful. We studied the effects of gabapentin (GBP) and carbamazepine (CBZ) on neurophysiologic and cognitive/behavioral measures in healthy volunteers. Methods: In a 12-week, randomized, double-blind, parallel-group study of CBZ and GBP in healthy volunteers, 23 subjects completed the protocol. All achieved the target dose of 1,200 mg CBZ or 3,600 mg GBP. A structured EEG for quantitative analysis and a cognitive test battery were administered before AED therapy and again after 12 weeks of therapy. Test-retest differences were compared with those of 72 untreated control subjects. Results: Both CBZ and GBP significantly decreased the peak frequency of the posterior (alpha) rhythm, with CBZ exerting a greater effect. Ten CBZ and six GBP subjects exceeded the 95% confidence interval (CI) for an individual. Cognitive tests revealed AED vs. control group effects for two of seven measures (Digit Symbol, Stroop) and all subjective measures. However, few subjects exceeded the 95% CI for any objective test. Differences between CBZ and GBP were not significant. Greater EEG slowing was associated with greater subjective neurotoxicity and poorer test-retest performance on a cognitive test summary measure. Conclusions: Prolonged CBZ and GBP therapy induced EEG slowing that correlated with cognitive complaints and often exceeded the confidence interval for individual subjects. Quantitative EEG measures may be useful in the objective determination of AED-related neurotoxicity.

KW - Antiepileptic drugs

KW - Carbamazepine

KW - Cognition

KW - Electroencephalography

KW - Epilepsy

KW - Gabapentin

UR - http://www.scopus.com/inward/record.url?scp=0036096850&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036096850&partnerID=8YFLogxK

U2 - 10.1046/j.1528-1157.2002.22501.x

DO - 10.1046/j.1528-1157.2002.22501.x

M3 - Article

C2 - 12027908

AN - SCOPUS:0036096850

VL - 43

SP - 482

EP - 490

JO - Epilepsia

JF - Epilepsia

SN - 0013-9580

IS - 5

ER -